Potency assay development uses DoE and QbD to improve accuracy, consistency, and regulatory readiness in biologics testing.

A new Armatus publication summarizes a novel potency assay platform to advance gene silencing therapies for rare neuromuscular diseases.

Assays are used in a diverse range of fields within the life sciences, and have become routine work in forensic, pharmaceutical, and microbiology labs. When designing an assay for any purpose, the ...

Optimization of experimental assay design is crucial for the overall success of any drug discovery initiative. The factors that need to be considered include: selection of the most appropriate assay ...

Biomarker testing identifies high-risk early-stage NSCLC patients for adjuvant chemotherapy, reducing recurrence risk by 78%. The AIM-HIGH study shows a 96% disease-free survival rate at 24 months ...

Fire assay analysis offers a highly accurate means of determining the contents of gold, silver and the platinum group metals in a range of materials, for example, slurries and ores. It is well suited ...

A diagnosis of perioperative myocardial infarction (MI) from coronary artery bypass grafting (CABG) surgery was hardly set in ...

Seed amplification assays, those PCR-like reactions for toxic misfolded proteins, are starting to look pretty good. In the May Lancet Neurology, scientists led by Andrew Siderowf, University of ...